FDA’s Office of Compliance details enforcement actions in 2021
Regulatory NewsJoanne S. Eglovitch
Audit/inspectionBiologics/ biosimilars/ vaccinesBiotechnologyComplianceNorth AmericaOTCPharmaceuticalsQuality Assurance and ControlRegulatory Intelligence/Policy